Oncologie Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $80M
Latest Deal Amount
  • Investors
  • 10

Oncologie General Information

Description

Developer of cancer therapies intended to improve the long-term survival of cancer patients worldwide. The company's proprietary, precision, RNA-based biomarker platform offers immune-modulatory monoclonal antibody combined with immune checkpoint inhibitors, enabling medical companies to improve patients' health.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 400 Totten Pond Road
  • Suite 120
  • Waltham, MA 02451
  • United States
+1 (781) 000-0000

Oncologie Timeline

20192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncologie Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 10-Jun-2019 $80M 000.00 Completed Clinical Trials - Phase 2
1. Seed Round 07-Jun-2018 000.00 000.00 Completed Clinical Trials - Phase 2
To view Oncologie’s complete valuation and funding history, request access »

Oncologie Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer therapies intended to improve the long-term survival of cancer patients worldwide. The company's pro
Drug Discovery
Waltham, MA
000.00
00000000000 000.00

0000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000 000000000
Farmington, CT
0 As of 0000
00.000
0000000000 00.000

00000000

ure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oncologie Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CaroGen Venture Capital-Backed Farmington, CT 0 00.000 0000000000 00.000
0000000000000 0000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000 - 000 00000
00000000 Venture Capital-Backed Sunnyvale, CA 00 00.000 0000000000 00.000
000000 Formerly VC-backed Seattle, WA 000 00000 00000000 00000
You’re viewing 5 of 40 competitors. Get the full list »

Oncologie Executive Team (5)

Name Title Board Seat Contact Info
Laura Benjamin Ph.D Founder, President & Chief Executive Officer
David Malek Interim Chief Business Officer
Hagop Youssoufian MD Interim Chief Medical Officer
Matthew Osborne Chief Financial Officer
To view Oncologie’s complete executive team members history, request access »

Oncologie Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Company K Partners Venture Capital Minority 000 0000 000000 0
Jiuyou Capital Venture Capital Minority 000 0000 000000 0
KB Investment Venture Capital Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
Panacea Venture Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »